01 1Corden Pharma Colorado, Inc.
02 1Lonza Tampa LLC
01 1Lonafarnib
02 1lonafarnib
01 1Germany
02 1U.S.A
NDC Package Code : 12869-230
Start Marketing Date : 2020-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70277-002
Start Marketing Date : 2020-11-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/500mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
A Lonafarnib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lonafarnib, including repackagers and relabelers. The FDA regulates Lonafarnib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lonafarnib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lonafarnib supplier is an individual or a company that provides Lonafarnib active pharmaceutical ingredient (API) or Lonafarnib finished formulations upon request. The Lonafarnib suppliers may include Lonafarnib API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lonafarnib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lonafarnib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lonafarnib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lonafarnib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lonafarnib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lonafarnib suppliers with NDC on PharmaCompass.
We have 2 companies offering Lonafarnib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
